Price target
28.000.00 0.00%
The 6 analysts offering 1 year price forecasts for ATNM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to ATNM in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ATNM EPS for the last quarter is −0.31 USD despite the estimation of −0.38 USD. In the next quarter EPS is expected to reach −0.41 USD. Track more of Actinium Pharmaceuticals, Inc. (Delaware) financials and stay on top of what is up with the company.
In the next quarter Actinium Pharmaceuticals, Inc. (Delaware) revenue is expected to reach 0 USD. Check out Actinium Pharmaceuticals, Inc. (Delaware) revenue and earnings and make informed decisions.
According to analysts, ATNM price target is 28.00 USD with a max estimate of 50.00 USD and a min estimate of 16.00 USD. Check if this forecast comes true in a year, meanwhile watch Actinium Pharmaceuticals, Inc. (Delaware) stock price chart and keep track of the current situation with ATNM news and stock market news.
We've gathered opinions of 6 analysts rating ATNM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.